ArticleRevista peruana de medicina experimental y salud publica2024

Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina.

Natalia Espinola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.